BrainChild Bio, Inc.
BrainChild Bio is seeking a Director of Regulatory Affairs, CMC to lead the execution of global CMC regulatory strategies for its clinical-stage cell therapy programs. The role involves overseeing regulatory submissions, guiding cross‑functional teams, and ensuring compliance with health authority requirements while supporting product quality and safety.
Company Size
1-10 employees
BrainChild Bio is a kids-first, clinical-stage biotechnology company developing CAR‑T cell therapies to treat tumors of the central nervous system (CNS). The company prioritizes pediatric patients while building a technology platform designed to expand into adult indications over time. BrainChild focuses on translating CAR‑T approaches tailored for the unique biology and delivery challenges of CNS tumors. Its goal is to bring new, durable cellular immunotherapies to children with brain and spinal cord tumors.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BrainChild Bio, Inc..
BrainChild Bio, Inc. didn’t post a salary, so this is our estimate from similar listings.
16% below the average for this role